Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Yep, just sucks. It is becoming very obvious this is just going to be played with between this $4 to $6 price range until we get trial data that is just SO GREAT that it just punches everybody in the face and can not be denied.
Then we can climb to the mid $20's where we should be now, and hopefully beyond.
You said: "I am betting heavily they are wrong."
I'm 62 now, been investing since mid 80's, I have never put this much $ in one stock, not even close, so if I'm right, great for me and patients around the world, if I'm wrong, that's why I put the "not" play money in real estate. But, if I am wrong, it's still going to suck big time as it will be about 80% of my stock investing money.
Probably stupid of me to put that many eggs in one basket, but I just believed in MRKR just so damn much, and really, still do.

The last several months have just been a few goof ups, ie: no ASCO, premature AACR release, compounded by whoever the "downward pressure" people are, whoever you want to blame for this.

BUT IN REALITY, no matter WHAT has happened in the last few months, what do we know to be FACTS.

FACT, the pancreatic data was GOOD NEWS.

FACT, Still NO cytokine release syndrome

FACT, Still epitope spreading.

FACT, look at the market cap of ALLO at 3.3 billion and ask …
WTF is going on here?